Stefano Pergolizzi
Overview
Explore the profile of Stefano Pergolizzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
1180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
La Rocca M, Leonardi B, Lo Greco M, Marano G, Milazzotto R, Liardo R, et al.
Diseases
. 2025 Feb;
13(2).
PMID: 39997068
Methods: We retrospectively analyzed the clinical data of two-hundred and three patients treated with retrobulbar radiotherapy between January 2002 and June 2023. Ninety-nine patients were treated with a schedule of...
2.
Lo Greco M, Marano G, La Rocca M, Acquaviva G, Milazzotto R, Liardo R, et al.
Cancers (Basel)
. 2025 Feb;
17(3).
PMID: 39941789
Despite recent advancements in radiotherapy for Diffuse Intrinsic Pontine Glioma (DIPG), the prognosis of this disease remains poor, highlighting the need for new treatment strategies to improve outcomes. Adding stereotactic...
3.
Laudicella R, Bauckneht M, Burger I, Cacciola A, Fanti S, Farolfi A, et al.
Eur J Nucl Med Mol Imaging
. 2025 Feb;
PMID: 39934300
Purpose: Conventional systemic therapies are valuable options in prostate cancer (PCa); however, such treatments can determine adverse events and toxicity. The observed improvement in overall survival, coupled with PSA reduction...
4.
Zagardo V, Pergolizzi S, Ferini G
Oral Oncol
. 2025 Jan;
161():107174.
PMID: 39787984
No abstract available.
5.
Zagardo V, Martorana E, Harikar M, Pergolizzi S, Ferini G
Discov Oncol
. 2024 Oct;
15(1):531.
PMID: 39377996
Aims: To investigate whether the addition of radiotherapy could be an appropriate option to delay the time-to-next systemic treatment (TTNsT) in patients with oligoprogressive solid tumors who had acquired or...
6.
Ferini G, Zagardo V, Viola A, Patane D, Parisi S, Cuccia F, et al.
In Vivo
. 2024 Aug;
38(5):2484-2493.
PMID: 39187357
Background/aim: To evaluate the safety and efficacy of lattice radiotherapy (LRT) for large, inoperable breast cancers. Patients And Methods: In this prospective study, patients who underwent LRT for breast tumors...
7.
Pontoriero A, Critelli P, Zeppieri M, Brogna A, Angileri F, Bottari A, et al.
Ann Ital Chir
. 2024 Aug;
95(4):510-521.
PMID: 39186353
Oncocytic lesions represent a group of benign and potentially precancerous tumors characterized by the accumulation of oncocytes, which are large, granular, and eosinophilic cells. Diagnosing oncocytic lesions in the parotid...
8.
Lattice radiotherapy in inflammatory breast cancer: report of a first case treated with curative aim
Parisi S, Sciacca M, Critelli P, Ferrantelli G, Chillari F, Venuti V, et al.
Radiat Oncol J
. 2024 Jul;
42(2):160-165.
PMID: 38946079
Inflammatory breast cancer (IBC) is a rare, aggressive form of breast cancer characterized by poor prognosis. The treatment requires a multidisciplinary approach, with neoadjuvant chemotherapy, surgery, and radiation therapy (RT)....
9.
Lo Greco M, Marano G, Milazzotto R, Liardo R, Finocchiaro I, La Rocca M, et al.
J Pers Med
. 2024 Jun;
14(6).
PMID: 38929802
In this retrospective case series, we investigate the synergistic effect and the immunomodulatory potential of combination radiotherapy and immunotherapy on 11 patients affected by locally advanced or metastatic cutaneous squamous...
10.
Zagardo V, Pergolizzi S, Ferini G
Oral Oncol
. 2024 Jun;
155:106880.
PMID: 38850767
No abstract available.